Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).
Updated: Lobbying group BIO restructures staff in shakeup under new CEO
The trade group BIO has parted ways with 30 employees, including several senior leaders, in what sources are describing as a restructuring of the trade